Genetics of nephrotic syndrome: Connecting molecular genetics to podocyte physiology

Human Molecular Genetics

Volumn 18, Issue R2, 2009, Pages

  Machuca, Eduardo ^a,b   Benoit, Geneviève ^a,c   Antignac, Corinne ^a,d  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSITY OF MONTREAL   (Canada)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CELL MEMBRANE; GENETICS; HUMAN; LYSOSOME; MITOCHONDRION; MOLECULAR BIOLOGY; NEPHROTIC SYNDROME; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PODOCYTE; REVIEW;

ANIMALS; CELL-MATRIX JUNCTIONS; HUMANS; LYSOSOMES; MITOCHONDRIA; MOLECULAR BIOLOGY; NEPHROTIC SYNDROME; PODOCYTES;

EID: 77950515351     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp328     Document Type: Article

References (94)

1. Haraldsson, B., Nystrom, J. and Deen, W.M. (2008) Properties of the glomerular barrier and mechanisms of proteinuria. Physiol. Rev., 88, 451-487.
2. Neal, C.R., Crook, H., Bell, E., Harper, S.J. and Bates, D.O. (2005) Three-dimensional reconstruction of glomeruli by electron microscopy reveals a distinct restrictive urinary subpodocyte space. J. Am. Soc. Nephrol., 16, 1223-1235.
3. Artero, M.L., Sharma, R., Savin, V.J. and Vincenti, F. (1994) Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am. J. Kidney Dis., 23, 574-581.
4. Dantal, J., Bigot, E., Bogers, W., Testa, A., Kriaa, F., Jacques, Y., Hurault de Ligny, B., Niaudet, P., Charpentier, B. and Soulillou, J.P. (1994) Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N. Engl. J. Med., 330, 7-14.
5. Dantal, J., Godfrin, Y., Koll, R., Perretto, S., Naulet, J., Bouhours, J.F. and Soulillou, J.P. (1998) Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome. J. Am. Soc. Nephrol., 9, 1709-1715.
6. Savin, V.J., Sharma, R., Sharma, M., McCarthy, E.T., Swan, S.K., Ellis, E., Lovell, H., Warady, B., Gunwar, S., Chonko, A.M. et al. (1996) Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N. Engl. J. Med., 334, 878-883.
7. Le Berre, L., Herve, C., Buzelin, F., Usal, C., Soulillou, J.P. and Dantal, J. (2005) Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo/Mna rats. Kidney Int., 68, 2079-2090.
8. Weber, S., Gribouval, O., Esquivel, E.L., Moriniere, V., Tete, M.J., Legendre, C., Niaudet, P. and Antignac, C. (2004) NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int., 66, 571-579.
9. Ruf, R.G., Lichtenberger, A., Karle, S.M., Haas, J.P., Anacleto, F.E., Schultheiss, M., Zalewski, I., Imm, A., Ruf, E.M., Mucha, B. et al. (2004) Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J. Am. Soc. Nephrol., 15, 722-732.
10. Winn, M.P. (2008) 2007 Young Investigator Award: TRP'ing into a new era for glomerular disease. J. Am. Soc. Nephrol., 19, 1071-1075.
11. Conlon, P.J., Butterly, D., Albers, F., Rodby, R., Gunnells, J.C. and Howell, D.N. (1995) Clinical and pathologic features of familial focal segmental glomerulosclerosis. Am. J. Kidney Dis., 26, 34-40.
12. Kestila, M., Lenkkeri, U., Mannikko, M., Lamerdin, J., McCready, P., Putaala, H., Ruotsalainen, V., Morita, T., Nissinen, M., Herva, R. et al. (1998) Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol. Cell., 1, 575-582.
13. Boute, N., Gribouval, O., Roselli, S., Benessy, F., Lee, H., Fuchshuber, A., Dahan, K., Gubler, M.C., Niaudet, P. and Antignac, C. (2000) NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat. Genet., 24, 349-354.
14. Kim, J.M., Wu, H., Green, G., Winkler, C.A., Kopp, J.B., Miner, J.H., Unanue, E.R. and Shaw, A.S. (2003) CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science, 300, 1298-1300.
15. Kaplan, J.M., Kim, S.H., North, K.N., Rennke, H., Correia, L.A., Tong, H.Q., Mathis, B.J., Rodriguez-Perez, J.C., Allen, P.G., Beggs, A.H. et al. (2000) Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat. Genet., 24, 251-256.
16. Patrakka, J. and Tryggvason, K. (2007) Nephrin-a unique structural and signaling protein of the kidney filter. Trends Mol. Med., 13, 396-403.
17. Hartleben, B., Schweizer, H., Lubben, P., Bartram, M.P., Moller, C.C., Herr, R., Wei, C., Neumann-Haefelin, E., Schermer, B., Zentgraf, H. et al. (2008) Neph-Nephrin proteins bind the Par3-Par6-atypical protein kinase C (aPKC) complex to regulate podocyte cell polarity. J. Biol. Chem., 283, 23033-23038.
18. Garg, P., Verma, R., Nihalani, D., Johnstone, D.B. and Holzman, L.B. (2007) Neph1 cooperates with nephrin to transduce a signal that induces actin polymerization. Mol. Cell. Biol., 27, 8698-8712.
19. Pritchard-Jones, K., Fleming, S., Davidson, D., Bickmore, W., Porteous, D., Gosden, C., Bard, J., Buckler, A., Pelletier, J., Housman, D. et al. (1990) The candidate Wilms' tumour gene is involved in genitourinary development. Nature, 346, 194-197.
20. Hinkes, B., Wiggins, R.C., Gbadegesin, R., Vlangos, C.N., Seelow, D., Nurnberg, G., Garg, P., Verma, R., Chaib, H., Hoskins, B.E. et al. (2006) Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat. Genet., 38, 1397-1405.
21. Reiser, J., Polu, K.R., Moller, C.C., Kenlan, P., Altintas, M.M., Wei, C., Faul, C., Herbert, S., Villegas, I., Avila-Casado, C. et al. (2005) TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat. Genet., 37, 739-744.
22. Faul, C., Asanuma, K., Yanagida-Asanuma, E., Kim, K. and Mundel, P. (2007) Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell. Biol., 17, 428-437.
23. Kao, W.H., Klag, M.J., Meoni, L.A., Reich, D., Berthier-Schaad, Y., Li, M., Coresh, J., Patterson, N., Tandon, A., Powe, N.R. et al. (2008) MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat. Genet., 40, 1185-1192.
24. Kopp, J.B., Smith, M.W., Nelson, G.W., Johnson, R.C., Freedman, B.I., Bowden, D.W., Oleksyk, T., McKenzie, L.M., Kajiyama, H., Ahuja, T.S. et al. (2008) MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat. Genet., 40, 1175-1184.
25. Hinkes, B., Vlangos, C., Heeringa, S., Mucha, B., Gbadegesin, R., Liu, J., Hasselbacher, K., Ozaltin, F. and Hildebrandt, F. (2008) Specific podocin mutations correlate with age of onset in steroid-resistant nephrotic syndrome. J. Am. Soc. Nephrol., 19, 365-371.
26. Hinkes, B.G., Mucha, B., Vlangos, C.N., Gbadegesin, R., Liu, J., Hasselbacher, K., Hangan, D., Ozaltin, F., Zenker, M. and Hildebrandt, F. (2007) Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1 and LAMB2). Pediatrics, 119, e907-e919.
27. Gbadegesin, R., Hinkes, B.G., Hoskins, B.E., Vlangos, C.N., Heeringa, S.F., Liu, J., Loirat, C., Ozaltin, F., Hashmi, S., Ulmer, F. et al. (2008) Mutations in PLCE1 are a major cause of isolated diffuse mesangial sclerosis (IDMS). Nephrol. Dial. Transplant., 23, 1291-1297.
28. Gbadegesin, R., Bartkowiak, B., Lavin, P.J., Mukerji, N., Wu, G., Bowling, B., Eckel, J., Damodaran, T. and Winn, M.P. (2009) Exclusion of homozygous PLCE1 (NPHS3) mutations in 69 families with idiopathic and hereditary FSGS. Pediatr. Nephrol., 24, 281-285.
29. Koziell, A., Grech, V., Hussain, S., Lee, G., Lenkkeri, U., Tryggvason, K. and Scambler, P. (2002) Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional inter-relationship in glomerular filtration. Hum. Mol. Genet., 11, 379-388.
30. Philippe, A., Nevo, F., Esquivel, E.L., Reklaityte, D., Gribouval, O., Tete, M.J., Loirat, C., Dantal, J., Fischbach, M., Pouteil-Noble, C. et al. (2008) Nephrin mutations can cause childhood-onset steroid-resistant nephrotic syndrome. J. Am. Soc. Nephrol., 19, 1871-1878.
31. Liu, L., Done, S.C., Khoshnoodi, J., Bertorello, A., Wartiovaara, J., Berggren, P.O. and Tryggvason, K. (2001) Defective nephrin trafficking caused by missense mutations in the NPHS1 gene: insight into the mechanisms of congenital nephrotic syndrome. Hum. Mol. Genet., 10, 2637-2644.
32. Roselli, S., Moutkine, I., Gribouval, O., Benmerah, A. and Antignac, C. (2004) Plasma membrane targeting of podocin through the classical exocytic pathway: effect of NPHS2 mutations. Traffic, 5, 37-44.
33. Ohashi, T., Uchida, K., Uchida, S., Sasaki, S. and Nihei, H. (2003) Intracellular mislocalization of mutant podocin and correction by chemical chaperones. Histochem. Cell Biol., 119, 257-264.
34. Kitamura, A., Tsukaguchi, H., Hiramoto, R., Shono, A., Doi, T., Kagami, S. and Iijima, K. (2007) A familial childhood-onset relapsing nephrotic syndrome. Kidney Int., 71, 946-951.
35. Shono, A., Tsukaguchi, H., Kitamura, A., Hiramoto, R., Qin, X.S., Doi, T. and Iijima, K. (2009) Predisposition to relapsing nephrotic syndrome by a nephrin mutation that interferes with assembly of functioning microdomains. Hum. Mol. Genet., 18, 2943-2956.
36. Machuca, E., Hummel, A., Nevo, F., Dantal, J., Martinez, F., Al-Sabban, E., Baudouin, V., Abel, L., Grunfeld, J.P. and Antignac, C. (2009) Clinical and epidemiological assessment of steroid-resistant nephrotic syndrome associated with the NPHS2 R229Q variant. Kidney Int., 75, 727-735.
37. Ratelade, J., Lavin, T.A., Muda, A.O., Morisset, L., Mollet, G., Boyer, O., Chen, D.S., Henger, A., Kretzler, M., Hubner, N. et al. (2008) Maternal environment interacts with modifier genes to influence progression of nephrotic syndrome. J. Am. Soc. Nephrol., 19, 1491-1499.
38. Papeta, N., Chan, K.T., Prakash, S., Martino, J., Kiryluk, K., Ballard, D., Bruggeman, L.A., Frankel, R., Zheng, Z., Klotman, P.E. et al. (2009) Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression. J. Clin. Invest., 119, 1178-1188.
39. Quaggin, S.E. (2006) A new piece in the nephrotic puzzle. Nat. Genet., 38, 1360-1361.
40. Shih, N.Y., Li, J., Karpitskii, V., Nguyen, A., Dustin, M.L., Kanagawa, O., Miner, J.H. and Shaw, A.S. (1999) Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science, 286, 312-315.
41. Gigante, M., Pontrelli, P., Montemurno, E., Roca, L., Aucella, F., Penza, R., Caridi, G., Ranieri, E., Ghiggeri, G.M. and Gesualdo, L. (2009) CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS). Nephrol. Dial. Transplant., 24, 1858-1864.
42. Lowik, M.M., Groenen, P.J., Pronk, I., Lilien, M.R., Goldschmeding, R., Dijkman, H.B., Levtchenko, E.N., Monnens, L.A. and van den Heuvel, L.P. (2007) Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation. Kidney Int., 72, 1198-1203.
43. Winn, M.P., Conlon, P.J., Lynn, K.L., Farrington, M.K., Creazzo, T., Hawkins, A.F., Daskalakis, N., Kwan, S.Y., Ebersviller, S., Burchette, J.L. et al. (2005) A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science, 308, 1801-1804.
44. Weins, A., Kenlan, P., Herbert, S., Le, T.C., Villegas, I., Kaplan, B.S., Appel, G.B. and Pollak, M.R. (2005) Mutational and Biological Analysis of alpha-actinin-4 in focal segmental glomerulosclerosis. J. Am. Soc. Nephrol., 16, 3694-3701.
45. Prakash, S., Chung, K.W., Sinha, S., Barmada, M., Ellis, D., Ferrell, R.E., Finegold, D.N., Randhawa, P.S., Dinda, A. and Vats, A. (2003) Autosomal dominant progressive nephropathy with deafness: linkage to a new locus on chromosome 11q24. J. Am. Soc. Nephrol., 14, 1794-1803.
46. Vats, A., Nayak, A., Ellis, D., Randhawa, P.S., Finegold, D.N., Levinson, K.L. and Ferrell, R.E. (2000) Familial nephrotic syndrome: clinical spectrum and linkage to chromosome 19q13. Kidney Int., 57, 875-881.
47. Pollak, M.R., Alexander, M.P. and Henderson, J.M. (2007) A case of familial kidney disease. Clin. J. Am. Soc. Nephrol., 2, 1367-1374.
48. Winn, M.P., Conlon, P.J., Lynn, K.L., Howell, D.N., Slotterbeck, B.D., Smith, A.H., Graham, F.L., Bembe, M., Quarles, L.D., Pericak-Vance, M.A. et al. (1999) Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity. Genomics, 58, 113-120.
49. Liu, G., Kaw, B., Kurfis, J., Rahmanuddin, S., Kanwar, Y.S. and Chugh, S.S. (2003) Neph1 and nephrin interaction in the slit diaphragm is an important determinant of glomerular permeability. J. Clin. Invest., 112, 209-221.
50. Jones, N., Blasutig, I.M., Eremina, V., Ruston, J.M., Bladt, F., Li, H., Huang, H., Larose, L., Li, S.S., Takano, T. et al. (2006) Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature, 440, 818-823.
51. Zhu, J., Sun, N., Aoudjit, L., Li, H., Kawachi, H., Lemay, S. and Takano, T. (2008) Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes. Kidney Int., 73, 556-566.
52. Huber, T.B., Hartleben, B., Kim, J., Schmidts, M., Schermer, B., Keil, A., Egger, L., Lecha, R.L., Borner, C., Pavenstadt, H. et al. (2003) Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol. Cell. Biol., 23, 4917-4928.
53. Lehtonen, S., Zhao, F. and Lehtonen, E. (2002) CD2-associated protein directly interacts with the actin cytoskeleton. Am. J. Physiol. Renal Physiol., 283, F734-F743.
54. Huber, T.B., Hartleben, B., Winkelmann, K., Schneider, L., Becker, J.U., Leitges, M., Walz, G., Haller, H. and Schiffer, M. (2009) Loss of Podocyte aPKC{lambda}/{iota} Causes Polarity Defects and Nephrotic Syndrome. J. Am. Soc. Nephrol., 20, 798-806.
55. Weins, A., Schlondorff, J.S., Nakamura, F., Denker, B.M., Hartwig, J.H., Stossel, T.P. and Pollak, M.R. (2007) Disease-associated mutant alpha-actinin-4 reveals a mechanism for regulating its F-actin-binding affinity. Proc. Natl. Acad. Sci. U.S.A., 104, 16080-16085.
56. Otey, C.A., Pavalko, F.M. and Burridge, K. (1990) An interaction between alpha-actinin and the beta 1 integrin subunit in vitro. J. Cell. Biol., 111, 721-729.
57. Dandapani, S.V., Sugimoto, H., Matthews, B.D., Kolb, R.J., Sinha, S., Gerszten, R.E., Zhou, J., Ingber, D.E., Kalluri, R. and Pollak, M.R. (2007) Alpha-actinin-4 is required for normal podocyte adhesion. J. Biol. Chem., 282, 467-477.
58. Wing, M.R., Bourdon, D.M. and Harden, T.K. (2003) PLC-epsilon: a shared effector protein in Ras-, Rho-, and G alpha beta gamma-mediated signaling. Mol. Interv., 3, 273-280.
59. Lehtonen, S., Ryan, J.J., Kudlicka, K., Iino, N., Zhou, H. and Farquhar, M.G. (2005) Cell junction-associated proteins IQGAP1, MAGI-2, CASK, spectrins, and alpha-actinin are components of the nephrin multiprotein complex. Proc. Natl. Acad. Sci. U.S.A., 102, 9814-9819.
60. Nilius, B., Owsianik, G., Voets, T. and Peters, J.A. (2007) Transient receptor potential cation channels in disease. Physiol. Rev., 87, 165-217.
61. Spassova, M.A., Hewavitharana, T., Xu, W., Soboloff, J. and Gill, D.L. (2006) A common mechanism underlies stretch activation and receptor activation of TRPC6 channels. Proc. Natl. Acad. Sci. U.S.A., 103, 16586-16591.
62. Huber, T.B., Schermer, B. and Benzing, T. (2007) Podocin organizes ion channel-lipid supercomplexes: implications for mechanosensation at the slit diaphragm. Nephron. Exp. Nephrol., 106, e27-e31.
63. Hisatsune, C., Kuroda, Y., Nakamura, K., Inoue, T., Nakamura, T., Michikawa, T., Mizutani, A. and Mikoshiba, K. (2004) Regulation of TRPC6 channel activity by tyrosine phosphorylation. J. Biol. Chem., 279, 18887-18894.
64. Schlondorff, J., Del Camino, D., Carrasquillo, R., Lacey, V. and Pollak, M.R. (2009) TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription. Am. J. Physiol. Cell Physiol., 296, C558-C569.
65. Sasaki, T., Fassler, R. and Hohenester, E. (2004) Laminin: the crux of basement membrane assembly. J. Cell. Biol., 164, 959-963.
66. Miner, J.H. and Patton, B.L. (1999) Laminin-11. Int. J. Biochem. Cell Biol., 31, 811-816.
67. Zenker, M., Aigner, T., Wendler, O., Tralau, T., Muntefering, H., Fenski, R., Pitz, S., Schumacher, V., Royer-Pokora, B., Wuhl, E. et al. (2004) Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum. Mol. Genet., 13, 2625-2632.
68. Zenker, M., Tralau, T., Lennert, T., Pitz, S., Mark, K., Madlon, H., Dotsch, J., Reis, A., Muntefering, H. and Neumann, L.M. (2004) Congenital nephrosis, mesangial sclerosis, and distinct eye abnormalities with microcoria: an autosomal recessive syndrome. Am. J. Med. Genet. A, 130, 138-145.
69. Wuhl, E., Kogan, J., Zurowska, A., Matejas, V., Vandevoorde, R.G., Aigner, T., Wendler, O., Lesniewska, I., Bouvier, R., Reis, A. et al. (2007) Neurodevelopmental deficits in Pierson (microcoria-congenital nephrosis) syndrome. Am. J. Med. Genet. A, 143, 311-319.
70. Choi, H.J., Lee, B.H., Kang, J.H., Jeong, H.J., Moon, K.C., Ha, I.S., Yu, Y.S., Matejas, V., Zenker, M., Choi, Y. et al. (2008) Variable phenotype of Pierson syndrome. Pediatr. Nephrol., 23, 995-1000.
71. Matejas, V., Al-Gazali, L., Amirlak, I. and Zenker, M. (2006) A syndrome comprising childhood-onset glomerular kidney disease and ocular abnormalities with progressive loss of vision is caused by mutated LAMB2. Nephrol. Dial. Transplant., 21, 3283-3286.
72. Hasselbacher, K., Wiggins, R.C., Matejas, V., Hinkes, B.G., Mucha, B., Hoskins, B.E., Ozaltin, F., Nurnberg, G., Becker, C., Hangan, D. et al. (2006) Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders. Kidney Int., 70, 1008-1012.
73. El-Aouni, C., Herbach, N., Blattner, S.M., Henger, A., Rastaldi, M.P., Jarad, G., Miner, J.H., Moeller, M.J., St-Arnaud, R., Dedhar, S. et al. (2006) Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis. J. Am. Soc. Nephrol., 17, 1334-1344.
74. Tran, U.C. and Clarke, C.F. (2007) Endogenous synthesis of coenzyme Q in eukaryotes. Mitochondrion, 7 (suppl), S62-S71.
75. Rotig, A., Appelkvist, E.L., Geromel, V., Chretien, D., Kadhom, N., Edery, P., Lebideau, M., Dallner, G., Munnich, A., Ernster, L. et al. (2000) Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet, 356, 391-395.
76. Salviati, L., Sacconi, S., Murer, L., Zacchello, G., Franceschini, L., Laverda, A.M., Basso, G., Quinzii, C., Angelini, C., Hirano, M. et al. (2005) Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition. Neurology, 65, 606-608.
77. Rahman, S., Hargreaves, I., Clayton, P. and Heales, S. (2001) Neonatal presentation of coenzyme Q10 deficiency. J. Pediatr., 139, 456-458.
78. Forsgren, M., Attersand, A., Lake, S., Grunler, J., Swiezewska, E., Dallner, G. and Climent, I. (2004) Isolation and functional expression of human COQ2, a gene encoding a polyprenyl transferase involved in the synthesis of CoQ. Biochem. J., 382, 519-526.
79. Diomedi-Camassei, F., Di Giandomenico, S., Santorelli, F.M., Caridi, G., Piemonte, F., Montini, G., Ghiggeri, G.M., Murer, L., Barisoni, L., Pastore, A. et al. (2007) COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J. Am. Soc. Nephrol., 18, 2773-2780.
80. Lopez, L.C., Schuelke, M., Quinzii, C.M., Kanki, T., Rodenburg, R.J., Naini, A., Dimauro, S. and Hirano, M. (2006) Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am. J. Hum. Genet., 79, 1125-1129.
81. Saiki, R., Lunceford, A.L., Shi, Y., Marbois, B., King, R., Pachuski, J., Kawamukai, M., Gasser, D.L. and Clarke, C.F. (2008) Coenzyme Q10 supplementation rescues renal disease in Pdss2kd/kd mice with mutations in prenyl diphosphate synthase subunit 2. Am. J. Physiol. Renal Physiol., 295, F1535-F1544.
82. Montini, G., Malaventura, C. and Salviati, L. (2008) Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N. Engl. J. Med., 358, 2849-2850.
83. Goto, Y., Nonaka, I. and Horai, S. (1990) A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature, 348, 651-653.
84. Jansen, J.J., Maassen, J.A., van der Woude, F.J., Lemmink, H.A., van den Ouweland, J.M., t' Hart, L.M., Smeets, H.J., Bruijn, J.A. and Lemkes, H.H. (1997) Mutation in mitochondrial tRNA(Leu(UUR)) gene associated with progressive kidney disease. J. Am. Soc. Nephrol., 8, 1118-1124.
85. Kurogouchi, F., Oguchi, T., Mawatari, E., Yamaura, S., Hora, K., Takei, M., Sekijima, Y., Ikeda, S. and Kiyosawa, K. (1998) A case of mitochondrial cytopathy with a typical point mutation for MELAS, presenting with severe focal-segmental glomerulosclerosis as main clinical manifestation. Am. J. Nephrol., 18, 551-556.
86. Berkovic, S.F., Dibbens, L.M., Oshlack, A., Silver, J.D., Katerelos, M., Vears, D.F., Lullmann-Rauch, R., Blanz, J., Zhang, K.W., Stankovich, J. et al. (2008) Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis. Am. J. Hum. Genet., 82, 673-684.
87. Reczek, D., Schwake, M., Schroder, J., Hughes, H., Blanz, J., Jin, X., Brondyk, W., Van Patten, S., Edmunds, T. and Saftig, P. (2007) LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. Cell, 131, 770-783.
88. Arrondel, C., Vodovar, N., Knebelmann, B., Grunfeld, J.P., Gubler, M.C., Antignac, C. and Heidet, L. (2002) Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J. Am. Soc. Nephrol., 13, 65-74.
89. Drenckhahn, D. and Franke, R.P. (1988) Ultrastructural organization of contractile and cytoskeletal proteins in glomerular podocytes of chicken, rat, and man. Lab. Invest., 59, 673-682.
90. Fuchshuber, A., Gribouval, O., Ronner, V., Kroiss, S., Karle, S., Brandis, M. and Hildebrandt, F. (2001) Clinical and genetic evaluation of familial steroid-responsive nephrotic syndrome in childhood. J. Am. Soc. Nephrol., 12, 374-378.
91. Landau, D., Oved, T., Geiger, D., Abizov, L., Shalev, H. and Parvari, R. (2007) Familial steroid-sensitive nephrotic syndrome in Southern Israel: clinical and genetic observations. Pediatr. Nephrol., 22, 661-669.
92. Ruf, R.G., Fuchshuber, A., Karle, S.M., Lemainque, A., Huck, K., Wienker, T., Otto, E. and Hildebrandt, F. (2003) Identification of the first gene locus (SSNS1) for steroid-sensitive nephrotic syndrome on chromosome 2p. J. Am. Soc. Nephrol., 14, 1897-1900.
93. Nakamura, T., Oite, T., Shimizu, F., Matsuyama, M., Kazama, T., Koda, Y. and Arakawa, M. (1986) Sclerotic lesions in the glomeruli of Buffalo/ Mna rats. Nephron, 43, 50-55.
94. Le Berre, L., Godfrin, Y., Perretto, S., Smit, H., Buzelin, F., Kerjaschki, D., Usal, C., Cuturi, C., Soulillou, J.P. and Dantal, J. (2001) The Buffalo/Mna rat, an animal model of FSGS recurrence after renal transplantation. Transplant. Proc., 33, 3338-3340.